Furthermore, miR-582 was significantly associated with OS by targeting CD1B. Recently, a phase I trial of patients with advanced NSCLC suggested that intratumoral vaccination with autologous DCs could increase infiltration of CD8+ T cells into tumors and increase the expression levels of PD-L1 [34]. This evidence concerns the gene CD1B and non-small cell lung carcinoma.